Clinical Trial Update: An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the pharmacological interaction between lopinavir/ritonavir and rifampin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• Kaletra (Lopinavir/ritonavir) (lopinavir/ritonavir)
• Rifadin (Rifampin) (rifampin)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: HIV Infection, Tuberculosis | Phase 4 | Status: COMPLETED